Cell adhesion molecules (CAMs) play crucial roles in the genesis and progress of tumor. We investigated the effects of single nucleotide polymorphisms (SNPs) of CAMs, neuronal growth regulator 1 (NEGR1), and Otoancorin (OTOA) on lung cancer susceptibility in Chinese nonsmoking females. Logistic regression and Cox regression analyses were conducted to investigate the effects of SNPs and environmental factors. For rs3102911, genotype TT carriers decreased the risk of lung cancer with an odds ratio (OR) of 0.635. AA genotypes of rs741718 increased the risk of lung cancer with an OR of 3.527. In stratified analysis, genotype AA carriers of rs741718 had a high susceptibility to lung adenocarcinoma compared with GG and AG genotypes. Analyses of association between SNPs and clinical characteristics revealed that rs3102911 as a protective factor and rs741718 as a risk factor influenced the lung cancer occurrence and progression in nonsmoking females.
Get full access to this article
View all access options for this article.
References
1.
BaruaS., KuizonS., ChadmanK.K., FloryM.J., BrownW.T., and JunaidM.A. (2014). Single-base resolution of mouse offspring brain methylome reveals epigenome modifications caused by gestational folic acid. Epigenet Chromatin 7,3.
2.
BertrandF.E., AngusC.W., PartisW.J., and SigounasG. (2012). Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch. Cell Cycle, 11, 4344–4351.
3.
BrayF., FerlayJ., SoerjomataramI., SiegelR.L., TorreL.A., and JemalA. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68, 394–424.
4.
CuiY., YingY., van HasseltA., NgK.M., YuJ., ZhangQ., et al. (2008). OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLoS One 3,e2990.
5.
FangJ.Y., and RichardsonB.C. (2005). The MAPK signalling pathways and colorectal cancer. Lancet Oncol, 6, 322–327.
6.
GovE., and ArgaK.Y. (2017). Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancer. Sci Rep 7,4996.
7.
HeX., WangL., RiedelH., WangK., YangY., DinuC.Z., et al. (2017). Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells. Mol Cancer 16,63.
8.
HechtS.S. (2012). Lung carcinogenesis by tobacco smoke. Int J Cancer, 131, 2724–2732.
9.
HofmannO., CaballeroO.L., StevensonB.J., ChenY.T., CohenT., ChuaR., et al. (2008). Genome-wide analysis of cancer/testis gene expression. Proc Natl Acad Sci U S A, 105, 20422–20427.
10.
HuangS., and IngberD.E. (1999). The structural and mechanical complexity of cell-growth control. Nat Cell Biol, 1, E131–E138.
11.
JovineL., ParkJ., and WassarmanP.M. (2002). Sequence similarity between stereocilin and otoancorin points to a unified mechanism for mechanotransduction in the mammalian inner ear. BMC Cell Biol 3,28.
12.
KimH., HwangJ.S., LeeB., HongJ., and LeeS. (2014). Newly identified cancer-associated role of human neuronal growth regulator 1 (NEGR1). J Cancer, 5, 598–608.
13.
KubiczkovaL., SedlarikovaL., HajekR., and SevcikovaS. (2012). TGF-beta - an excellent servant but a bad master. J Transl Med 10,183.
14.
LiH., RenY., XiaL., QuR., KongL., YinZ., et al. (2016). Association of microRNA-149 polymorphism with lung cancer risk in chinese non-smoking female: a case-control study. PLoS One 11,e0163626.
15.
LoeffF.C., RijsK., van EgmondE.H.M., ZoutmanW.H., QiaoX., KroesW.G.M., et al. (2019). Loss of the GPI-anchor in B-lymphoblastic leukemia by epigenetic downregulation of PIGH expression. Am J Hematol, 94, 93–102.
16.
LovrencićM., JakovacI., KumarH., and PopovN. (1977). “Amipaque”—a watersoluble, non-ionic contrast medium for cervical, thoracal and lumbosacral myelography (author's transl). Lijecnicki Vjesnik, 99, 683–687.
17.
LuuP.L., SchölerH.R., and Araúzo-BravoM.J. (2013). Disclosing the crosstalk among DNA methylation, transcription factors, and histone marks in human pluripotent cells through discovery of DNA methylation motifs. Genome Res, 23, 2013–2029.
18.
MacArthurI.C., BeiY., GarciaH.D., OrtizM.V., ToedlingJ., KlironomosF., et al. (2019b). Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastoma. JCI insight. 5,e127130.
19.
McKieA.B., VaughanS., ZaniniE., OkonI.S., LouisL., de SousaC., et al. (2012). The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer. Cancer Discov, 2, 156–171.
20.
MorelloA., SadelainM., and AdusumilliP.S. (2016). Mesothelin-targeted CARs: driving T cells to solid tumors. Cancer Discov, 6, 133–146.
21.
MuminovaZ.E., StrongT.V., and ShawD.R. (2004). Characterization of human mesothelin transcripts in ovarian and pancreatic cancer. BMC Cancer 4,19.
22.
NichenametlaS.N., MuscatJ.E., LiaoJ.G., LazarusP., and RichieJ.P.Jr. (2013). A functional trinucleotide repeat polymorphism in the 5'-untranslated region of the glutathione biosynthetic gene GCLC is associated with increased risk for lung and aerodigestive tract cancers. Mol Carcinog, 52, 791–799.
23.
NoreenF., KungT., TornilloL., ParkerH., SilvaM., WeisS., et al. (2019). DNA methylation instability by BRAF-mediated TET silencing and lifestyle-exposure divides colon cancer pathways. Clin Epigenet 11,196.
24.
PaulickM.G., and BertozziC.R. (2008). The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins. Biochemistry, 47, 6991–7000.
25.
PolakisP. (2000). Wnt signaling and cancer. Genes Dev, 14, 1837–1851.
26.
PritchardK.I. (2008). Who should participate in clinical trials and who not?. Can clinical trials be made more efficient and effective? Breast Cancer Res 10 Suppl 4,S23.
27.
RuanL., XieY., LiuF., and ChenX. (2018). Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study. Eur J Obstet Gynecol Reprod Biol, 222, 31–38.
28.
RukhG., SonestedtE., MelanderO., HedbladB., WirfältE., EricsonU., et al. (2013). Genetic susceptibility to obesity and diet intakes: association and interaction analyses in the Malmö Diet and Cancer Study. Gene Nutr, 8, 535–547.
29.
SahaS., AnilkumarA.A., and MayorS. (2016). GPI-anchored protein organization and dynamics at the cell surface. J Lipid Res, 57, 159–175.
30.
SathyanarayanaB.K., HahnY., PatankarM.S., PastanI., and LeeB. (2009). Mesothelin, stereocilin, and otoancorin are predicted to have superhelical structures with ARM-type repeats. BMC Struct Biol 9,1.
31.
ScanlanM.J., SimpsonA.J., and OldL.J. (2004). The cancer/testis genes: review, standardization, and commentary. Cancer Immun 4,1.
32.
SinghK., JayaramM., KaareM., LeidmaaE., JagomaeT., HeinlaI., et al. (2019). Neural cell adhesion molecule Negr1 deficiency in mouse results in structural brain endophenotypes and behavioral deviations related to psychiatric disorders. Sci Rep 9,5457.
33.
TakitaJ., ChenY., OkuboJ., SanadaM., AdachiM., OhkiK., et al. (2011). Aberrations of NEGR1 on 1p31 and MYEOV on 11q13 in neuroblastoma. Cancer Sci, 102, 1645–1650.
34.
TanR.P.A., Leshchyns'kaI., and SytnykV. (2017). Glycosylphosphatidylinositol-anchored immunoglobulin superfamily cell adhesion molecules and their role in neuronal development and synapse regulation. Front Mol Neurosci 10,378.
35.
WakeleeH.A., ChangE.T., GomezS.L., KeeganT.H., FeskanichD., ClarkeC.A., et al. (2007). Lung cancer incidence in never smokers. J Clin Oncol, 25, 472–478.
36.
WillerC.J., SpeliotesE.K., LoosR.J., LiS., LindgrenC.M., HeidI.M., et al. (2009). Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet, 41, 25–34.
37.
XiB., TakeuchiF., MeirhaegheA., KatoN., ChambersJ.C., MorrisA.P., et al. (2014). Associations of genetic variants in/near body mass index-associated genes with type 2 diabetes: a systematic meta-analysis. Clin Endocrinol, 81, 702–710.
38.
YangS., NingQ., ZhangG., SunH., WangZ., and LiY. (2016). Construction of differential mRNA-lncRNA crosstalk networks based on ceRNA hypothesis uncover key roles of lncRNAs implicated in esophageal squamous cell carcinoma. Oncotarget, 7, 85728–85740.
39.
YuX.J., YangM.J., ZhouB., WangG.Z., HuangY.C., WuL.C., et al. (2015). Characterization of somatic mutations in air pollution-related lung cancer. EBioMed, 2, 583–590.
40.
YurugiH., MariniF., WeberC., DavidK., ZhaoQ., BinderH., et al. (2017). Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours. Oncogene, 36, 4778–4789.
41.
ZhangL., LiX., QuanX., TianW., YangX., and ZhouB. (2019a). A case/control study: AGBL1 polymorphism related to lung cancer risk in Chinese nonsmoking females. DNA Cell Biol, 38, 1452–1459.
42.
ZhangX.X., NiB., LiQ., HuL.P., JiangS.H., LiR.K., et al. (2019b). GPAA1 promotes gastric cancer progression via upregulation of GPI-anchored protein and enhancement of ERBB signalling pathway. J Exp Clin Cancer Res 38,214.
43.
ZhengC., LiX., QianB., FengN., GaoS., ZhaoY., et al. (2018). The lncRNA myocardial infarction associated transcript-centric competing endogenous RNA network in non-small-cell lung cancer. Cancer Manag Res, 10, 1155–1162.
44.
ZhengR.S., SunK.X., ZhangS.W., ZengH.M., ZouX.N., ChenR., et al. (2019). [Report of cancer epidemiology in China, 2015]. Zhonghua Zhong Liu Za Zhi, 41, 19–28.
45.
ZhuF., HuangR., LiJ., LiaoX., HuangY., and LaiY. (2018). Identification of key genes and pathways associated with RUNX1 mutations in acute myeloid leukemia using bioinformatics analysis. Med Sci Monit, 24, 7100–7108.
46.
ZhuX., XuY., SolisL.M., TaoW., WangL., BehrensC., et al. (2015). Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment. Proc Natl Acad Sci U S A, 112, 7779–7784.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
